The aim of this work was to characterize the effect of experimental diabetes on neurotransmission in rat vagina. Female Sprague ± Dawley rats were divided into two groups: non-diabetic controls (NDM, n 38) and diabetics (DM, n 38). DM was produced by intraperitoneal injection of streptozotocin. Eight weeks later the animals were killed, the distal part of the vagina was removed, and smooth muscle strips were prepared for functional organ bath experiments and for measurement of nitric oxide synthase (NOS) activity. In DM preparations, the EC 50 value for noradrenaline (NA) was signi®cantly increased (P`0.05) and the maximal contractile response decreased (P 5 0.001). In preparations precontracted with NA, the NO donor SNAP and calcitonin gene-related peptide (CGRP) caused concentration-dependent relaxations, which were signi®cantly decreased (P`0.001) in the DM group. Electrical stimulation of nerves (EFS) caused frequency-dependent contractions, which were signi®cantly lower in DM than in NDM strips (P`0.001). SNAP and CGRP concentration-dependently inhibited EFS evoked contractions in both NDM and DM preparations. The inhibition was signi®cantly lower (P`0.05) in the DM group. In NDM preparations precontracted with NA, EFS evoked frequency-dependent relaxations; such relaxations were inhibited or reduced in DM. Treatment with the NOS inhibitor, L-NOARG 0.1 mM, abolished relaxations in all preparations or produced contraction in DM preparations. Calcium-dependent NOS activity was not signi®cantly different in the DM and NDM groups. However, the DM animals showed a small but signi®cant increase in calcium-independent NOS-activity (P`0.05). Diabetes interferes with adrenergic-, cholinergic-and NANC-neurotransmitter mechanisms in the smooth muscle of the rat vagina. The changes in the nitrergic neurotransmission are not due to reduction in NOS-activity, but seem to be due to interference with later steps in the L-arginineaNOaguanylate cyclaseacGMP system.
Introduction
The female sexual response is a multifactorial event depending on physiological, psychological, social, and emotional factors, and can be described in the terms of desire, arousal and orgasm. 1 The arousal response consists of psychological and physiological components. One of the physiological responses is lubrication of the vagina, which may be caused by either physical or psychological stimuli or both.
Similar to the erectile mechanism in males, the physiological arousal response relies on vaginal and vascular smooth muscle relaxation, and thereby increased vaginal blood¯ow. The increase in blood ow is re¯ex-mediated and results in vasocongestion followed by transudation of¯uid into the vaginal lumen. 2 Several studies have been performed to identify the neurotransmitters involved in the regulation of the smooth muscle of the vaginal wall and vascular bed. In the human and animal vagina, adrenergic-, cholinergic-as well as non-adrenergic, non-cholinergic (NANC)-neurotransmittersatransmitter generating enzymes have been identi®ed as described previously. 3 However the exact role of these neurotransmitter systems in the regulation of vascular and vaginal smooth muscle during the sexual response still remains to be established.
It is well known that diabetic men develop erectile dysfunction more often and earlier than non-diabetic men. 4 One important pathophysiological factor is diabetes-related alterations in neurotransmission and signal transduction in cavernosal and arterial smooth muscle, especially changes in the nitric oxide (NO) system. 5 Sexual function and dysfunction in diabetic women are much less clear than in males. Despite con¯icting reports, there is an indication that diabetic women develop arousal disorders more often than non-diabetic women. 6 Given the clear correlation between diabetes, erectile dysfunction and impaired smooth muscle function and neurotransmission in erectile tissue in men, it seems reasonable to assume that similar mechanisms exist in the smooth muscle important for the female arousal response, and thereby may play a role in female arousal disorders in diabetic women. No studies have, to our knowledge, been performed to investigate a possible diabetesrelated change in the properties of the smooth muscle cells involved in the female sexual arousal response. Therefore, the aim of the present study was to characterize the effect of experimentally induced diabetes on neurotransmission in rat vaginal smooth muscle.
Materials and methods

Animal preparation and pretreatment
A total of 76 mature female Sprague ± Dawley rats (Charles River, Germany), weighing 185 ± 204 g were used in these experiments. All rats were fed with Altromin 1314 rodent laboratory chow and water ad libitum. The rats were housed in cages with maximum of ®ve animals in each cage with a 12 ± 12 h light cycle.
Experimental induction of diabetes
The rats were subdivided into two groups. Animals (n 38) were made diabetic by an intraperitoneal injection of streptozotocin (STZ) (45 mgakg) dissolved in citrate buffer. They became hyperglycaemic within 24 h. The extent of diabetes was monitored twice by blood analysis. The rats were included in the diabetic group when fasting (12 h) blood glucose was higher than 10 mmolal and non-fasting higher than 15 mmolal. Blood sugar was controlled on tail blood using a Gluco Touch TM, Lifescan system. The diabetic rats (DM) remained untreated for 8 weeks.
Control animals (NDM) (n 38) were injected intraperitoneally with the citrate-buffer alone. They underwent the same procedures as the diabetic rats.
Tissue preparation
The rats were killed by asphyxia after 8 weeks. The mean weight of the diabetic animals was 200 AE 4 g, and that of the control group 257 AE 3 g. After killing the animals a vaginal smear was done in order to determine the oestrous cycles of the animals, as described by Giraldi et al. 3 Blood glucose was measured in blood from the carotid artery. Thereafter the abdomen was opened and the uterus, bladder and vagina were removed and placed in chilled Krebs Ringer (for composition see below). Subsequently vaginal strips were prepared. The strips were taken from the distal part of vagina in a circular direction. Tissue strips for NOS measurement were rapidly frozen and kept at 780 C until the experiment was carried out. Tissue strips for organ bath experiments (16167 mm) were transferred to 5 ml temperature regulated (37 C) organ baths containing Krebs solution continuously bubbled with a mixture of 95% O 2 and 5% CO 2 resulting in a pH of 7.4. For registration of isometric tension the tissue strips were suspended between two L-shaped metal hooks by silk ligations. One hook was connected to a Grass force transducer (FTO3), the other was attached to a movable unit allowing adjustment of tissue tension. Isometric tension was recorded using a Grass polygraph (7D).
Electrical ®eld stimulation
For electrical ®eld simulation (EFS) platinum electrodes were placed parallel to the tissue strips and as close as possible without touching the tissue. Transmural stimulation of nerves was performed using a Grass S88 stimulator delivering single wave pulses (0.8 ms) at supramaximal voltage. The train duration was 5 ms and the interval between the stimulations was 120 s.
Experimental procedure
After mounting, the tissue strips were stretched to a passive tension of 4 ± 5 mN and allowed to equilibrate for 60 min. To assess the contractile capacity of the tissue strips, each experiment was started by exposing the preparation to a K (124 mM) solution (for composition see below). The following experiments were then performed in the diabetic and control groups:
Concentration ± response curves were constructed for noradrenaline (NA) by cumulative 
Measurement of NOS-activity
Determination of NOS-activity was made in duplicate, and each determination was derived from a pooled sample of vaginal tissue from three animals. NOS-activity was determined by measuring the formation of L-[ 14 C]citrulline from L-[ 14 C]arginine. 12 The tissue was homogenized in ice-cold buffer using a glass pestle homogenizer. Homogenization buffer (pH 7.2) contained: 20 mM HEPES, 0.5 mM EDTA and a protease inhibitor cocktail. Homogenates were centrifuged at 20 000 g for 30 min at 4
C to obtain the cytosolic fraction.
Cytosolic fractions were passed over a column of AG5OW-X8 resin to remove endogenous arginine and the ef¯uent used for NOS-and protein assays. Incubation mixtures contained 75 ml of cytosolic fractions and 25 ml of homogenization buffer containing (®nal concentrations): 2 mM NADPH, 1 mM CaCl 2 , 30 Uaml calmodulin, 3 mM tetrahydro-L-biopterin, 40 mM L-arginine and 0.8 mM L-[ 14 C]arginine. The samples were incubated for 45 min at 37 C in a shaking water bath. Preliminary experiments showed that the reaction was linear during this time. Incubation was terminated by the addition of 1.5 ml ice-cold stop buffer (5 mM HEPES, 2 mM EDTA pH 5.5). Samples were passed through a 1 ml column of AG5OW-X8 resin and eluted with 2 ml of stop buffer. Radioactivity of the ef¯uent was measured by liquid scintillation spectrometry. A parallel set of incubations was performed on ice and was considered as non-speci®c activity. To examine Ca 2 -dependence, some experiments were performed in the absence of CaCl 2 and calmodulin but in the presence of 2 mM EGTA. The activity in the presence of the NOS-inhibitors L-NMMA (2 mM) EGTA (2 mM) was also studied. Ca 2 -independent NOS-activity (iNOS) was determined as the difference between samples containing EGTA and samples containing L-NMMA EGTA. Ca 2 -dependent activity (nNOS andaor eNOS) was calculated by subtracting the Ca 2 -independent activity from total NOS activity. Protein concentrations were determined using bovine serum albumin as standard. The speci®c NOS activity was expressed as pmol citrullineamg proteinamin.
Drugs and solutions
The Krebs solution had the following composition (mM): NaCl 119, KCl 4.6, CaCl 2 1.5, MgCl 2 1.2, NaHCO 3 
Statistical analysis
Contractile effects of EFS and NA have been expressed as percentage of the tension elicited by high K (124 mM). Relaxant effects of agonists on EFS contractions were expressed as percentage reduction of maximum contraction prior to addition of agonist. Agonist relaxation of NA precontracted preparations was expressed as percentage reduction of the NA-induced tension.
The values are given as mean AE s.e. of the mean and statistical analysis were performed as two way ANOVA. A probability of P`0.05 was considered as signi®cant. Small n denotes the number of strip preparations, and capital N the number of animals.
The NA concentration ± response curve data were constructed using the ALLFIT 2.12 for windows software. The curves were ®tted to the logistic equation:
where E is the observed effect, E max and E min the calculated maximal and minimal effect, respec-
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Results
Functional effects
Relaxation of NA-contracted preparations. NA produced concentration-related contractions of the vaginal smooth muscle strips from both NDM (Nan 6a8) and DM (Nan 8a8) ( Figure 1 ). However in the DM groups the contractile effect of NA was signi®cantly reduced compared to the controls when using ANOVA for comparison between the curves (P`0.001). between DM tissues and NDM tissues. SNAP (10 78 ± 10 74 M) concentration-dependently relaxed both NDM (Nan 8a8) and DM (Nan 7a8) preparations precontracted by NA (Figure 2) . However in the DM group the relaxing effect of SNAP was signi®cantly reduced compared to NDM (P`0.05). In both DM and NDM a maximal relaxing effect was obtained at a concentration of 10 74 M (37 AE 8% and 77 AE 10%, respectively).
Vaginal preparations precontracted by NA were also concentration-dependently relaxed by CGRP (10 710 ± 10 76 M) (NDM; Nan 8a8 DM; Nan 8a8) revealing a signi®cantly (P`0.001) reduced relaxant effect in the DM group compared to NDM. In both groups maximum effect was obtained at 10 76 M (DM, 34 AE 9% and NDM, 61 AE 9%; Figure 3) .
VIP had no effect on precontracted vaginal preparations from DM (Nan 4a4) and NDM (Na n 4a4) (data not shown).
Inhibition of EFS-induced contractions.
Electrical stimulation induced frequency-dependent contractions of the preparations (Figure 4 ). In the DM group (Nan 6a7) the contractile effect was signi®cantly reduced compared to NDM (Nan 6a6, P`0.001). Maximal response was found at 40 Hz in DM and NDM, 91% AE 15% and 122% AE 27%, respectively. The EFS induced contractions were blocked by the a-adrenoceptor (AR)-antagonists prazosin and phentolamine as shown in Figure 5 . In preparations repeatedly contracted by EFS, SNAP induced 
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concentration-dependent inhibition of the contractions in both DM (Nan 7a7) and NDM (Nan 5a5) ( Figure 6 ). The inhibition was signi®cantly higher in NDM than in DM (P`0.001). In both groups maximum inhibition was obtained at 10 74 M. In DM, SNAP inhibited the contractions to 65 AE 6% of baseline contraction. In NDM, the inhibition was to 35 AE 12%.
CGRP inhibited EFS induced contractions in a concentration-dependent manner in both DM (Nan 6a6) and control preparations (Nan 7a7) ( Figure 7 ). The inhibitory effect was signi®cantly lower (P`0.001) in the DM group than in the NDM group. Maximal inhibition was obtained at 10 77 710 76 M. In the NDM group, the contractions were reduced to 31% AE 5% of the contractile response before addition of CGRP. In the diabetic group maximal inhibition reduced the contractile response to 51% AE 9% of the preincubation response (a signi®cantly lower response, P`0.05).
EFS induced contractions were not affected by addition of VIP in either DM (Nan 4a4) or NDM (Nan 4a4) (data not shown).
Electrical stimulation of the NDM preparations precontracted by NA elicited frequency-dependent relaxations in all strips (Nan 7a7). Maximum relaxation was obtained at 30 Hz. Addition of Larginine (10 75 M) had no effect upon the response to EFS. Pretreatment with the NO synthase inhibitor L-NOARG (10 74 M) abolished the EFS induced relaxations at all frequencies and in four strips contractions were observed when stimulated with high frequencies as shown by an example in Figure 8 .
In the DM preparations, electrical stimulation of NA precontracted tissue resulted in frequencydependent relaxations at the low frequencies and in a biphasic response at higher frequencies in ®ve 
A Giraldi et al of seven strips. As shown in Figure 9 the biphasic response was always initiated by relaxation followed by contraction. Increasing frequency led to an enhanced contractile response. In one strip, EFS induced contractions at all frequencies and in one strip relaxations at all frequencies ( Figure 9 ). The responses to EFS were not changed by preincubation with L-arginine (10 75 M). After pretreatment with L-NOARG (10 74 M), EFS induced a frequency dependent contractile response in all preparations ( Figure 10 ).
Nitric oxide synthase activity
NOS activity was measured in NDM (Nan 18a6) and in DM (Nan 18a6). As shown in Table 1 , no differrence in total NOS activity between the groups was observed. To investigate whether diabetes induced changes in the different NOS isoforms, we measured the Ca 2 -dependence of the NOS activity.
No difference was found between Ca 2 -dependent NOS activity in the two groups, whilst a signi®cant increase (P`0.05) in Ca 2 -independent NOS activity was shown in the diabetic group.
Vaginal smears
Determination of stage of oestrus cycle in the nondiabetic group revealed an equal distribution between the four cycles: oestrus, pro-oestrus, metoestrus and dioestrus, with approximately 25% of the animals in each group. In the diabetic animals 80% were in dioestrous, 10% in metoestrus, and 5% in prooestrous and oestrus, respectively. Comparison of the contractile and relaxant capacity of the tissues revealed no in¯uence related to the cycles.
Discussion
Vaginal smooth muscle is one of many components that may be involved in the physiological sexual response in females. The musculature is regulated by adrenergic-, cholinergic-and NANC-mechanisms. 13 Alterations in the neural pathways (central and peripheral) to the smooth muscle cells, or of the reactivity to endogenous substances may have an impact on the physiological response during sexual arousal. 14 Some of these processes may be in¯uen-cedaimpacted by diabetes mellitus. The goal of the present study was two-fold: to investigate basic characteristics of rat vaginal smooth muscle cells with respect to contractilea relaxant signal transduction mechanisms, and to evaluate the effect of experimentally induced diabetes hereupon. NA contracted vaginal smooth muscle concentration-dependently, similar to what has been shown in vascular and penile smooth muscle. 15 Furthermore an a-AR-dependent contraction was elicited during nerve stimulation by EFS. These EFS-induced contractions were frequencydependent and could be blocked with prazosin and phentolamine. These ®ndings are in accordance with those of Kim et al, who found that in rabbit vaginal smooth muscle tissue, stimulation of a 1 and a 2 -ARs elicited contractions. 16 They are also in agreement with clinical studies showing that locally applied a-AR antagonists increased vaginal blood ow. 17 In tissue precontracted by NA or EFS, the NO donor, SNAP, and the neuropeptide, CGRP, caused concentration-dependent relaxations. This indicates that relaxation of vaginal smooth muscle may be elicited by stimulation of the cGMP-as well as the cAMP-system. The present ®ndings are in good accordance with those of Traish et al, who stimulated cAMP formation by prostaglandin E 1 or isoproterenol, and cGMP formation by sodium nitroprusside in cultured vaginal smooth muscle cells and vaginal strips from rabbits. 18 Surprisingly, no effect of VIP was found on NA or EFS contracted preparations in controls or in diabetics. These ®ndings are in contrast to those of Berman and colleagues, who showed that VIP was able to relax rabbit vaginal (lower as well as upper part) tissue strips in a concentration-dependent manner. 19 Immunohistochemical staining of vaginal tissue has shown abundant VIP containing nerve ®bers in smooth muscle tissue as well as in the vascular bed of both animals and humans. 3,20 ± 23 Furthermore, clinical studies have shown that VIP is able to increase vaginal blood¯ow. 24 The absence of effect in the present study, may re¯ect that the rat vaginal muscle has a low sensitivity to VIP, similar to what has been found in the bladder. 25 In the NA precontracted NDM vaginal tissue, EFS elicited a frequency-dependent relaxant response. Addition of L-arginine had no effect upon the EFSinduced relaxation, whilst the NOS-inhibitor L-NOARG abolished the relaxations at low frequencies in all control strips and resulted in contractions at higher frequencies in four out of seven strips. These results suggest that the relaxations produced by EFS are NO dependent, and similar to those found in urethral 26 and corporal 27 smooth muscle.
In tissues from DM animals, the contractile effect of NA was reduced signi®cantly and EC 50 was shifted to the right, showing a decreased ef®cacy of NA. The EFS-induced contractions, mediated through a-AR stimulation, were less pronounced in diabetic tissue than in controls. In smooth muscles from other tissues, the effect of diabetes upon a-ARmediated contractile responses has been contradictory. Kamata and Kirisawa found that the contractile response of vas deferens smooth muscle was signi®cantly impaired in 10-week-STZ-diabetic rats compared to controls. 28 However, the same group showed that in aortic strips, diabetes resulted in enhanced contractile response to NA compared to controls. 29 Christ et al showed a diabetes related increase in phenylephrine induced contractions of 8-weeks-STZ-rat aorta. 30 The changes to a more contractile state may be explained by an altered cellular Ca 2 distribution. 29, 31 Melman et al and Lincoln et al found a reduction of the NA content in nerve ®bers in corpus cavernosum from diabetic men compared to non-diabetics. 32, 33 These studies illustrate that with regard to a-ARmediated responses, diabetes-induced changes in smooth muscle may be organ andaor species dependent.
A major ®nding in the present study was the pronounced attenuation of the nitrergic system in the diabetic tissue. Diabetes clearly causes an impairment of this system as shown by the decreased effect of SNAP. Furthermore, nerve stimulation in the DM group elicited a contractile response, similar to that in NDM tissue with the NOsystem blocked. This is in good accordance with ®ndings in other uro-genital smooth muscle organs (corpus cavernosum and urethra), where it was shown that diabetes impairs nerve-mediated relaxation. 5, 34 In the vascular bed, several investigators have shown that diabetes causes impaired endothelium-dependent relaxation. 35 ± 38 Possible mechanisms behind the diabetes-related impairment of the NO system may be decreased releaseaformation of NO due to decreased NOS activity, 39 de®cit in the substrate availability, 35 alterations of the NOS binding sites, 34 reduction in nerve density, 33 or decreased sensitivity to NO. 36 In order to identify a possible step of the cGMP pathway responsible for the diabetes related impairment of the NO system in our experiments, investigations were carried out to measure NOS activity in tissue from diabetic and non-diabetic animals. We found a signi®cant increase in inducible NOS in diabetic rats compared to controls, whilst there was no difference between the two groups in Ca 2 -dependent NOS activity (e-and n-NOS). The increase in iNOS activity was most probably an in¯ammatory response to the generally poor condition of the diabetic rats, as it has been seen in other in¯ammatory processes. 40 In penile tissue, Seftel and colleagues hypothesized a possible Effects of diabetes on neurotransmission A Giraldi et al pathophysiologic mechanism by advanced glycation products mediating erectile dysfunction by upregulation of iNOS and down regulation of eNOS, a hypothesis that needs further investigation. 41 Our study suggested that the interference of diabetes with the nitrergic system is most probably due to a decreased responsiveness in signal transduction mechanisms downstream from the NOS activity level.
The present study revealed that diabetes impaired the relaxant responses to CGRP, showing that diabetes also impairs cAMP mediated smooth muscle relaxation. Sheykhzade et al found that in rat coronary arteries diabetes caused an attenuated CGRP relaxation compared to control 42 and Rittenhouse et al showed that in STZ-diabetic rats, CGRP synthesis in primary sensory neurones was reduced. 43 The oestrous cycles of the rats were determined at each experiment. The control rats were equally grouped in the different stages, whilst the diabetic rats were primarily in dioestrous. Hormonal changes may in¯uence the innervation of vagina. Adham and Schenk showed changes in density of adrenergic and cholinergic innervation during the oestrous cycle 44 and the NOS expression has been shown to be hormonally modulated. 45 ± 47 Given the difference between cycles of our control and DM rats one could speculate that the differences between the two groups are due to hormonal changes and not due to the diabetes. However, in the control tissues we could not observe any differences in the results related to the different phases, but the number of strips in each group was small and further experiments need to be performed to elucidate the possible role of hormonal changes upon the tissue response.
The clinical relevance of our ®ndings may be questioned. During the non-sexually stimulated state, the vagina may be in a predominantly contracted state due to adrenergic stimulation, as is cavernosal smooth muscles in the penis. 15 During arousal, vasodilatation and relaxation of vaginal smooth muscle is necessary in order to increase and facilitate vaginal blood¯ow and lubrication. 13 As in erectile function, this smooth muscle relaxation supposedly may rely upon NANC mechanisms. 13, 14 As in the male, the physiological relaxation response of smooth muscle seems to be in¯uenced by the diabetes-related changes in neurotransmission.
The consequences of a diminished contractile effect of NA in vaginal tissue are uncertain. Theoretically, it may enhance an arousal response during sexual stimulation, but this needs further investigation.
In conclusion we have shown that vaginal smooth muscle is regulated by adrenergic-, cholinergic-and NANC-neurotransmitter mechanisms, and that diabetes impairs these mechanisms. These diabetesrelated changes in neurotransmission may result in an inadequate physiological response during sexual stimulation.
